Intentions to Seek Information About the Influenza Vaccine: The Role of Informational Subjective Norms, Anticipated and Experienced Affect, and Information Insufficiency Among Vaccinated and Unvaccinated People

AbstractWhen deciding whether to vaccinate, people often seek information through consequential processes that are not currently well understood. A survey of a nationally representative sample of U.S. adults (N = 2,091) explored the factors associated with intentions to seek influenza vaccine information in the 2018 –2019 influenza season. This survey shed light on what motivates intentions to seek information about the influenza vaccine through the lens of the risk information seeking and processing (RISP) model. The model explained information‐seeking intentions well among both unvaccinated and vaccinated respondents. Key findings show that informational subjective norms, information insufficiency, and different types of affect are strong predictors of information‐seeking intentions. Theoretical insights on extending the RISP model and practical guidance on designing interventions are provided.
Source: Risk Analysis - Category: International Medicine & Public Health Authors: Tags: Original Research Article Source Type: research

Related Links:

Ajay Kohli Vinay Kohli Chitra Chhabra Kohli By CHITRA CHHABRA KOHLI MD, AJAY KOHLI MD, and VINAY KOHLI MD, MBA With a doubling time of cases estimated between 3 days within the U.S. and about 6 days globally (at the time of this writing) COVID-19 is demonstrating its terrifying virulence as it spreads across the world. What’s perhaps equally terrifying, if not more, is the absence of a known cure or treatment plan for COVID-19. While there has been a lot of attention focused on Hydroxychloroquine and Azithromycin, there has been debate on the scientific validity of these treatment options, either as t...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: COVID-19 Patients Physicians Ajay Kohli Azithromycin convalescent plasma therapy coronavirus COVID-19 treatment hydroxychloroquine Pandemic Vinay Kohli Source Type: blogs
Publication date: Available online 29 March 2020Source: American Journal of Infection ControlAuthor(s): Christopher Blank, Nancy Gemeinhart, W. Claiborne Dunagan, Hilary M. Babcock
Source: American Journal of Infection Control - Category: Infectious Diseases Source Type: research
As new cases appear in the U.S., some — including the president — have compared it to the seasonal flu. Here’s a close look at the differences.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Coronavirus (2019-nCoV) Quarantines Influenza Ventilators (Medical) Deaths (Fatalities) Tests (Medical) Epidemics Vaccination and Immunization SARS (Severe Acute Respiratory Syndrome) United States Politics and Government Pneumonia F Source Type: news
One chart explains why slowing the spread of the infection is nearly as important as stopping it.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Coronavirus (2019-nCoV) Quarantines Epidemics Shortages Hospitals Vaccination and Immunization Influenza Hygiene and Cleanliness Centers for Disease Control and Prevention Economist, The National Institute of Allergy and Infectious Dis Source Type: news
Basel, 27 March  2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) as well as two supplemental New Drug Applications (sNDA) for Xofluza® (baloxavir marboxil). The FDA accepted a NDA for a new formulation of Xofluza as one-dose granules for oral suspension (2 mg/mL), potentially offering a more convenient option for children and those who have difficulty swallowing. In addition, the application seeks approval of Xofluza for the treatment of acute uncomplicated influenza in otherwise healthy children aged one to l ess th...
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news
Jeffrey A. SingerOn March 24 Arizona Governor Doug Ducey issuedanexecutive order allowing CRNA ’s (Certified Registered Nurse Anesthetists) to practice independently of physicians or surgeons, thus adding needed personnel to the health care work force during this public health emergency. Guidelines issued by the Centers for Medicare and Medicaid Services state that nurse anesthetists should be “supervised” by a physician, thus preventing these well ‐​trained specialized nurses from providing anesthesia independently while freeing up physician anesthesiologists so more patients can receive ca...
Source: Cato-at-liberty - Category: American Health Authors: Source Type: blogs
Conditions:   Influenza;   Vaccination;   Health Promotion;   Health Behavior;   Risk Reduction Interventions:   Behavioral: Risk reduction;   Behavioral: Medical records-based recommendation;   Behavioral: Algorithm-based recommendation Sponsor:   Geisinger Clinic Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Right now, many people are hoping for a vaccine to protect against the new coronavirus. While that’s still on the horizon, new research suggests that families who do vaccinate their children may not be following the recommended schedule. Vaccines are given on a schedule for a reason: to protect children from vaccine-preventable disease. Experts designed the schedule so that children get protection when they need it — and the doses are timed so the vaccine itself can have the best effect. When parents don’t follow the schedule, their children may not be protected. And yet, many parents do not follow the sc...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Adolescent health Children's Health Parenting Vaccines Source Type: blogs
The New York Blood Center (NYBC) is the first blood-gathering organization in the U.S. to collect plasma from COVID-19 patients to use as a possible treatment for the disease. Before antibiotics rendered the practice moot, it was common to treat infectious bacterial diseases by infusing the blood of recovered patients into those struggling with infection. That approach has also been tried against viral infections like H1N1 influenza, SARS and MERS, with inconsistent success. Some patients benefited, but other did not and doctors don’t have a clear understanding of why. But during an evolving pandemic like COVID-19, p...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news
The recent WHO decision to declare the novel coronavirus outbreak a Public Health Emergency of International Concern (PHEIC), while both appropriate and hardly surprising, offers the opportunity to reflect on the previous PHEIC which was declared, namely the Ebola epidemic in Kivu region, Democratic Republic of the Congo (DRC). And you should really say the ongoing Ebola epidemic, as during the time since the declaration in July 2019 through to the present day (March 2020), a total of 3,453 cases have been reported [1]. The nCoV-2019 outbreak is still ballooning; as of today, over 400,000 confirmed cases worldwide with no ...
Source: GIDEON blog - Category: Databases & Libraries Authors: Tags: Ebooks Epidemiology Outbreaks Source Type: blogs
More News: Influenza | Influenza Vaccine | International Medicine & Public Health | Vaccines